The FDA has removed risk evaluation and mitigation strategies for CAR-T cell therapies, streamlining treatment for blood ...

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need.